Yuvraj Singh’s Protocol 32 supplement brand faces scientific criticism at launch

What Protocol 32 claims

Protocol 32, launched by Yuvraj Singh, is positioned as an invite-only supplement brand containing 32 ingredients approved by the Food Safety and Standards Authority of India (FSSAI). The brand claims these ingredients are included in "the right quantities for an average Indian."

The product was co-formulated with Dr. Anurag Agrawal and Dr. Arpit Bansal, and developed in collaboration with Prashant Pitti and Prasad CP in Bangalore.

Scientific objections raised

Dr. Cyriac Abby Philips, a hepatologist and scientist known for critiquing unscientific health claims, criticized the launch as "in very bad faith." He warned that 13 of the 32 ingredients in Protocol 32 pose documented risks, including organ toxicity, mineral toxicity, and the potential to promote atherosclerosis-inducing toxins.

Philips highlighted that nearly all 30 active ingredients lack rigorous scientific evidence supporting their promised health benefits. Eight ingredients, he noted, have no gold-standard human trials backing them, while two are inactive fillers. Six others rely on weaker data or are included solely for safety.

Among the ingredients flagged, Ashwagandha, Bacopa, Curcumin, and Boswellia are frequently implicated in liver injury cases recorded in LiverTox registries. Philips also described 11 ingredients as "fairy-dusted," meaning the sachets contain only minimal amounts—far below doses proven effective in human studies.

Cancer risk concerns

One of the most serious allegations from Philips involves the potential cancer risks associated with several ingredients in Protocol 32. He cited evidence suggesting that Vitamin E may increase prostate cancer risk, while a combination of folic acid and Vitamin B12 could elevate risks for lung and colon cancer. Additionally, NAC, Vitamin E, Vitamin C, and Astaxanthin were flagged for potentially accelerating tumor progression or increasing cancer spread in healthy adults.

Philips also expressed disappointment that Singh, a cancer survivor, did not leverage his platform to support evidence-based health initiatives. According to Philips, Singh "teamed up with unethical businessmen and one of the worst health influencers on the internet," undermining his potential role as an ally for cancer patients and oncology societies.

What this means

Lazyfounder analysis — our interpretation, not reported fact.

For founders and operators in the health and wellness space, this controversy underscores the risks of bringing supplement products to market without rigorous, peer-reviewed scientific backing. The criticism from a medical expert like Dr. Philips highlights how quickly a brand—even one backed by a celebrity—can face reputational damage if its claims are perceived as unscientific or misleading.

Startups in this sector must prioritize transparency about ingredient efficacy, dosages, and potential risks, especially when targeting health-conscious consumers. The debate also serves as a reminder of the regulatory and ethical tightrope walk involved in marketing supplements, where FSSAI approval alone may not suffice to address scientific scrutiny or public health concerns.

Related on Lazyfounder

• More health news